Page last updated: 2024-08-26

syringaresinol and Diabetic Nephropathies

syringaresinol has been researched along with Diabetic Nephropathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
An, J; Cui, J; Feng, L; Gao, Y; Li, G; Li, J; Liu, C; Liu, J; Pan, Z; Qi, Z; Wang, Y; Xu, Y; Yan, J; Yang, L; Zhang, S1

Other Studies

1 other study(ies) available for syringaresinol and Diabetic Nephropathies

ArticleYear
Syringaresinol protects against diabetic nephropathy by inhibiting pyroptosis via NRF2-mediated antioxidant pathway.
    Cell biology and toxicology, 2023, Volume: 39, Issue:3

    Topics: Animals; Antioxidants; Caspases; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Mice; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis

2023